EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 26 / No 8-9 (Août-Septembre 2010) Med Sci (Paris), 26 8-9 (2010) 761-767 References
Free Access
Issue
Med Sci (Paris)
Volume 26, Number 8-9, Août-Septembre 2010
Page(s) 761 - 767
Section Dossier technique
DOI https://doi.org/10.1051/medsci/2010268-8761
Published online 15 August 2010
  1. Peer D, Karp JM, Hong S, et al. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2007 ; 2 : 751-60. [Google Scholar]
  2. Couvreur P, Gref R, Andrieux K, Malvy C. Nanotechnology for drug delivery: Applications to cancer and autoimmune diseases. Prog Solid State Chem 2006 ; 34 : 231-5. [Google Scholar]
  3. Gref R, Minamitake Y, Peracchia MT, et al. Biodegradable long-circulating polymeric nanospheres. Science 1994 ; 263 : 1600-3. [Google Scholar]
  4. Gabizon A. Stealth liposomes and tumor targeting: One step further in the quest for the magic bullet. Clin Cancer Res 2001 ; 7 : 223-5. [Google Scholar]
  5. Hasan AS, Socha M, Lamprecht A, et al. Effect of the microencapsulation of nanoparticles on the reduction of burst release. Int J Pharm 2007 ; 344 : 53-61. [Google Scholar]
  6. Gref R, Minamitake Y, Peracchia MT, et al. Biodegradable long-circulating polymeric nanospheres. Science 1994 ; 263 : 1600-3. [Google Scholar]
  7. Couvreur P, Stella B, Reddy LH, et al. Squalenoyl nanomedicines as potential therapeutics Nano Lett 2006 ; 6 : 2544-8. [Google Scholar]
  8. Férey G. Hybrid porous solids: past, present, future. Chem Soc Rev 2008 ; 37 : 191-241. [Google Scholar]
  9. Férey G, Serre C. Large breathing effects in three-dimensional porous hybrid matter: facts, analyses, rules and consequences. Chem Soc Rev 2009 ; 38 :1380-99. [Google Scholar]
  10. Llewellyn PL, Bourrelly S, Serre C, et al. High uptakes of CO2 and CH4 in mesoporous metal organic frameworks MIL-100 and MIL-101. Langmuir 2008 ; 24 : 7245-50. [Google Scholar]
  11. Horcajada P, Serre C, Vallet-Regf M, et al. Metal_organic frameworks as efficient materials for drug delivery. Angew Chem Int Ed Engl 2006 ; 45 : 5974-8. [Google Scholar]
  12. Horcajada P, Serre C, Maurin G, et al. Flexible porous metal organic frameworks for a controlled drug delivery. J Am Chem Soc 2008 ; 130 : 6774-80. [Google Scholar]
  13. Horcajada P, Serre C, Gref R, et al. Nanoparticules hybrides organiques inorganiques à base de carboxylates de fer. PCT applications PCT/FR2008/001366, 1er octobre 2008. [Google Scholar]
  14. Horcajada P, Serre C, Gref R, et al. Solides hybrides organique-inorganique à surface modifiée. PCT applications PCT/FR2008/001367, 1er octobre 2008. [Google Scholar]
  15. Sheftel VO. Indirect food additives and polymers: migration and toxicology. Boca Raton : Lewis Publishers, 2000 : 148-54. [Google Scholar]
  16. http://www.chem.unep.ch/irptc/sids/0ECDSIDS/100-21-0.pdf> (2008). [Google Scholar]
  17. http://www.chemicalland21.com/specialtychem/perchem/TRIMESIC %20ACID.htm> (2008). [Google Scholar]
  18. http://www.sciencelab.com/xMSDS-Fumaric_acid-9927173> (2008). [Google Scholar]
  19. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983 ; 65 : 55-63. [Google Scholar]
  20. Vauthier C, Dubernet C, Chauvierre C, et al. Drug delivery to resistant tumors: the potential of poly(alkyl cyanoacrylate) nanoparticles. J Control Release 2003 ; 93 : 151-60. [Google Scholar]
  21. Vassal G, Deroussent A, Challine D, et al. Is 600mg.m−2 the appropriate dosage of busulfan in children undergoing bone marrow transplantation? Blood 1992 ; 79 : 2475-9. [Google Scholar]
  22. Vassal G, Gouyette A, Hartmann O, et al. Pharmacokinetics of high-dose busulfan in children. Cancer Chemother Pharmacol 1989 ; 24 : 386-90. [Google Scholar]
  23. Slattery JT, Sanders JE, Buckner CD, et al. Graft-rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics. Bone Marrow Transplant 1995 ; 16 : 31-42. [Google Scholar]
  24. Layre A, Gref R, Richard J, et al. Nanoparticules polymériques composites. FR 04 07569, 7 juillet 2004. [Google Scholar]
  25. Hassan Z, Nilsson C, Hassan M. Liposomal busulphan: bioavailability and effect on bone marrow in mice. Bone Marrow Transplant 1998 ; 22 : 913-8. [Google Scholar]
  26. Thierry AR, Vigé D, Coughlin SS, et al. Modulation of doxorubicin resistance in multidrug-resistant cells by liposomes. FASEB J 1993 ; 7 : 572-9. [Google Scholar]
  27. Loke SL, Stein CA, Zhang XH, et al. Characterization of oligonucleotide transport into living cells. Proc Natl Acad Sci USA 1989 ; 86 : 3474-8. [Google Scholar]
  28. Kukhanova M, Krayevsky A, Prusoff W, Cheng YC. Design of anti-HIV compounds: From nucleoside to nucleoside 50-triphosphate analogs. Problems and perspectives. Curr Pharm Des 2000 ; 6 : 585-98. [Google Scholar]
  29. Hillaireau H, Le Doan T, Besnard M, et al. Encapsulation of antiviral nucleotide analogues azidothymidine-triphosphate and cidofovir in poly(isobutyl cyanoacrylate) nanocapsules. Int J Pharm 2006 ; 324 : 37-42. [Google Scholar]
  30. Taylor KM, Jin A, Lin W. Surfactant-assisted synthesis of nanoscale gadolinium metal_organic-framework for potential multimodal imaging. Angew Chem Int Ed Engl 2008 ; 47 : 7722-5. [Google Scholar]
  31. Horcajada P, Chalati T, Serre C, et al. Porous metal-organic framework nanoscale carriers as a potential platform for drug delivery and imaging. Nat Mater 2010 ; 9 : 172-8. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.